DNA FY 2023 Earnings — Ginkgo Bioworks Holdings, Inc. Revenue & Financial Results | Market Cap Arena

DNAGinkgo Bioworks Holdings, Inc.

$418M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$251M-47.4% YoY

Gross Profit

$197M78.5% margin

Operating Income

-$864M-343.8% margin

Net Income

-$893M-355.1% margin

EPS (Diluted)

$-18.40

Cash Flow

Operating Cash Flow

-$296M

Free Cash Flow

-$336M

Stock-Based Comp.

$230M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$568M

Stockholders' Equity

$1.1B

Cash & Equivalents

$944M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$251M	$478M	-47.4%
Gross Profit	$197M	$273M	-27.8%
Operating Income	-$864M	-$2.2B	+60.9%
Net Income	-$893M	-$2.1B	+57.6%